Bavarian Nordic A/S BAVA-DK:Copenhagen Stock Exchange

RT Quote | Exchange | DKK
Last | 4:59 PM CET
221.00quote price arrow down-4.00 (-1.78%)
Volume
289,159
52 week range
186.70 - 261.00

...

Loading . . .

KEY STATS

  • Open221.00
  • Day High225.60
  • Day Low216.40
  • Prev Close225.00
  • 52 Week High261.00
  • 52 Week High Date02/15/21
  • 52 Week Low186.70
  • 52 Week Low Date01/04/21
  • Market Cap2,309.41M
  • Shares Out58.41M
  • 10 Day Average Volume354,508.92
  • Dividend-
  • Dividend Yield-
  • Beta2.16
  • 1 Year % Change21.47

RATIOS/PROFITABILITY

  • EPS (TTM)14.17
  • P/E (TTM)15.60
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Bavarian Nordic A/S News

There is no recent news for this security.

Latest BAVA-DK News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate cancer, including PROSTVAC and Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) PRO; breast cancer, providing CV-301 breast and MVA-BN HER2...
Gerard van Odijk M.D.
Chairman
Anders Pedersen M.D., Ph.D.
Vice Chairman
Paul Chaplin Ph.D.
President
Henrik Birk
Chief Operating Officer
Henrik Juuel
Chief Financial Officer
Jean-Christophe May
Executive Vice President
Address
Philip Heymans Alle 3
Hellerup
2900
Denmark